Bright Minds Biosciences (DRUG) Total Liabilities (2020 - 2026)

For the quarter ending Q1 2026, Total Liabilities changed N/A year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Mar 2026, changed N/A, and an annual FY2025 reading of $1.7 million, up 314.57% over the prior year.

Bright Minds Biosciences (DRUG) has disclosed Total Liabilities for 6 consecutive years, with $2.8 million as the latest value for Q1 2026.

  • Total Liabilities reached $2.8 million in Q1 2026 per DRUG's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $2.8 million in Q1 2026 and bottomed at $209499.0 in Q3 2023.
  • Average Total Liabilities over 5 years is $1.3 million, with a median of $1.2 million recorded in 2022.
  • Year-over-year, Total Liabilities tumbled 82.31% in 2023 and then surged 314.57% in 2025.
  • Bright Minds Biosciences' Total Liabilities stood at $1.2 million in 2022, then plummeted by 82.31% to $209499.0 in 2023, then skyrocketed by 98.84% to $416564.2 in 2024, then skyrocketed by 314.57% to $1.7 million in 2025, then skyrocketed by 61.84% to $2.8 million in 2026.
  • Per Business Quant, the three most recent readings for DRUG's Total Liabilities are $2.8 million (Q1 2026), $1.7 million (Q3 2025), and $416564.2 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 16.35 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.74 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 177.22 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 7.12 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 9.45 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 10.44 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.05 Bn
10 Bright Minds Biosciences 464.72 Mn 405.19 Mn - 2.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.79 Mn
Dec 31, 2025 1.15 Mn
Sep 30, 2025 1.73 Mn
Jun 30, 2025 481,983.42
Mar 31, 2025 506,527.26
Dec 31, 2024 409,172.21
Sep 30, 2024 416,564.20
Jun 30, 2024 130,602.17
Mar 31, 2024 627,669.70
Dec 31, 2023 627,410.87
Sep 30, 2023 209,499.05
Jun 30, 2023 547,032.60
Mar 31, 2023 769,668.86
Dec 31, 2022 429,247.34
Sep 30, 2022 1.18 Mn
Jun 30, 2022 302,225.28
Mar 31, 2022 792,250.41
Dec 31, 2021 388,414.17
Sep 30, 2021 507,288.34
Sep 30, 2020 113,256.19